ZEJULA® (niraparib) - Maintenance Treatment for Recurrent Ovarian Canc

- zejula.com

ZEJULA® (niraparib) is a once-daily oral medicine used for maintenance treatment of women with recurrent ovarian, fallopian tube, or primary peritoneal cancer. See important safety information.

2,936,584 $ 480.00